Publications by authors named "Ahmed A Abulfathi"

Claim this Profile
C
Cabotegravir pharmacokinetics in Asians with and without HIV.
Kelong Han, Ahmed A Abulfathi, Rashmi S Mehta, Romina A Nand, Mark A Marzinke

Int J Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and safety analysis of ropivacaine used for erector spinae plane blocks.
Eric S Schwenk, Edwin Lam, Ahmed A Abulfathi, Stephan Schmidt, Anthony Gebhart

Reg Anesth Pain Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians.
Jessica M Aguilar Diaz, Ahmed A Abulfathi, Lindsey Hm Te Brake, Jakko van Ingen, Saskia Kuipers

Respiration· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Pharmacometrics-tools to assure optimal medicine use in low- and middle-income countries.
Ahmed A Abulfathi, Linda A Chaba, Elin M Svensson, Goonaseelan C Pillai, Bernd Rosenkranz

Front Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
Veronique De Jager, Nikhil Gupte, Silvia Nunes, Grace L Barnes, Rob Christiaan van Wijk, Ahmed A Abulfathi

Am J Respir Crit Care Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug concentration at the site of disease in children with pulmonary tuberculosis.
Elisa Lopez-Varela, Ahmed A Abulfathi, Natasha Strydom, Pierre Goussard, Abraham C van Wyk

J Antimicrob Chemother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis.
Ahmed A Abulfathi, Veronique de Jager, Elana van Brakel, Helmuth Reuter, Nikhil Gupte

Front Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmacokinetics of Crushed Levetiracetam Tablets Administered to Neonates.
Veshni Pillay-Fuentes Lorente, Adrie Bekker, Gugu T J Kali, Lizel G Lloyd, Alma W Van der Merwe, Ahmed A Abulfathi

J Trop Pediatr· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance.
Ahmed A Abulfathi, Peter R Donald, Kim Adams, Elin M Svensson, Andreas H Diacon

Br J Clin Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens.
Ahmed A Abulfathi, Piyanan Assawasuwannakit, Peter R Donald, Andreas H Diacon, Helmuth Reuter

Eur J Clin Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018.
Tessa du Toit, Tonya M Esterhuizen, Nicki Tiffin, Ahmed A Abulfathi, Helmuth Reuter

BMC Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance.
Kim T Adams, Peter R Donald, Ahmed A Abulfathi, Andreas H Diacon, Marietjie A Stander

J Clin Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.
Ahmed Aliyu Abulfathi, Eric H Decloedt, Elin M Svensson, Andreas H Diacon, Peter Donald

Clin Pharmacokinet· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations.
Ahmed A Abulfathi, Maxwell Chirehwa, Bernd Rosenkranz, Eric H Decloedt

J Clin Pharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis